logo-bullish-stock-alerts
  • About
    • FAQ
    • Client Reviews
    • Pricing
  • Contact
  • Investment portfolios
  • Blog
    • Investing Strategies
    • Market News
    • Cryptocurrency News
    • Investing Tools and Regulations
  • Login
    • My Account
    • Invoices
    • Edit Profile
Join our free newsletter!
Cassava Sciences Inc. (SAVA : un investissement stratégique dans la lutte contre la maladie d’Alzheimer) permet de réaliser des gains massifs

Cassava Sciences Inc. (SAVA : un investissement stratégique dans la lutte contre la maladie d’Alzheimer) permet de réaliser des gains massifs

by Aaron E. | Jul 19, 2024 | Investing Strategies

Introduction Cassava Sciences Inc. (NASDAQ : SAVA) est une société de biotechnologie à la pointe du développement de traitements innovants pour les maladies neurodégénératives, notamment la maladie d’Alzheimer. Avec son principal produit thérapeutique candidat,...
Find out why we’re all in on this growth opportunity : Palantir Technologies Inc !

Find out why we’re all in on this growth opportunity : Palantir Technologies Inc !

by Aaron E. | Jul 18, 2024 | Market News

Introduction Palantir Technologies Inc. (NYSE: PLTR) is a leading technology company specializing in software platforms for big data analytics. Known for its robust solutions catering to both commercial and government sectors, Palantir has been making waves with its...
Phunware Inc. ($PHUN): A Strategic Buy Ahead of Trump’s re-election

Phunware Inc. ($PHUN): A Strategic Buy Ahead of Trump’s re-election

by Aaron E. | Jul 17, 2024 | Market News

Introduction Phunware Inc. (NASDAQ: PHUN) is a technology company specializing in a Multiscreen-as-a-Service (MaaS) platform that provides enterprises with products, solutions, data, and services to engage, manage, and monetize mobile application portfolios and...
Citius Pharmaceuticals Inc. ($CTXR): Don’t Miss This Explosive Opportunity Before FDA Approval!

Citius Pharmaceuticals Inc. ($CTXR): Don’t Miss This Explosive Opportunity Before FDA Approval!

by Aaron E. | Jul 16, 2024 | Market News

Introduction Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a biopharmaceutical company dedicated to developing and commercializing critical care products, focusing on oncology, anti-infectives, and stem cell therapy. With a significant catalyst approaching—the PDUFA...
Citius Pharmaceuticals Inc. ($CTXR): Don’t Miss This Explosive Opportunity Before FDA Approval!

Citius Pharmaceuticals Inc. ($CTXR) : Ne manquez pas cette opportunité explosive avant l’approbation de la FDA !

by Aaron E. | Jul 16, 2024 | Investing Strategies

Introduction Citius Pharmaceuticals Inc. (NASDAQ : CTXR) est une société biopharmaceutique qui se consacre au développement et à la commercialisation de produits de soins intensifs, en se concentrant sur l’oncologie, les anti-infectieux et la thérapie par...
Next Entries »

Read more Investment Insights for Free


Explore Investment Categories

  • Cryptocurrency News
  • Investing Strategies
  • Investing Tools and Regulations
  • Investment Insights
  • Market News

Recent Market Alerts & Analysis

  • IBM (International Business Machines Corp)
  • JNJ (Johnson & Johnson)
  • HSBC Holdings (ADR)
  • Home Depot (HD): Quality Retail Giant… But Too Pricey to Build On?
  • Goldman Sachs (GS): Elite Banker on Fire… But Too Pricey to Chase?


Address

300 Park Avenue, 12th Floor New York, NY 10022, United States

}

Business hours

Open 24 hours from Monday to Sunday

Legal Notice

  • *Terms and conditions of sale
  • Privacy policy
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
Copyright © 2026 Bullish Stock Alerts. All Rights Reserved.